American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List

DALLAS, Dec 30 -- Gene therapy to grow new blood vessels to the heart, strong confirmation that "superaspirin" IIb/IIIa receptor blocker drugs prevent blood clots, the importance of inflammation throughout the blood in cardiovascular disease, and a study on the deadly effects of smoking fewer than 10 cigarettes a day are among the top 10 research advances in heart disease and stroke during 1998, says Valentin Fuster, M.D., Ph.D., president of the American Heart Association. The list, first created in 1996, recognizes achievements in basic and clinical research that may have the greatest impact in improving the prevention and treatment of cardiovascular disease, the nation's No.1 killer.

1. Gene therapy to create a "natural" bypass to circumvent plaque obstructions in the heart's blood vessels
In the next century many people with heart disease may be routinely treated with a genetically engineered therapy that induces the growth of new blood vessels to and from the heart. These new vessels would help restore blood flow to the hearts of people whose arteries are obstructed by fat-laden plaque. By impeding blood flow, these fatty obstructions can cause severe chest pain, heart attacks and strokes. Gene therapy may become an adjunct to other therapies for heart disease, which now include low saturated fat diets, exercise, smoking cessation, and, if appropriate, medications such as cholesterol-lowering drugs and the surgical procedures of cardiac bypass surgery and angioplasty. Gene therapy to create natural bypasses is described in research published this year in Circulation: Journal of the American Heart Association. This research was also presented at the 71st Scientific Sessions, AHA's largest medical conference, in November. "At the American Heart Association's meeting in 1997, scientists described very preliminary research findings that unlocked the door to using gene therapy for heart disease," says Fuster. "This past year, researchers op

Contact: Cathy Yarbrough
American Heart Association

Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: